Masaya Yokoyama
Chuo, 2608670, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Short-term sodium-glucose cotransporter 2 inhibition with ipragliflozin enhances engraftment and function in murine islet transplantation.
Journal: Transplant immunology
Published: February 24, 2026
Soluble PD-L1 Concentration Is Proportional to the Expression of PD-L1 in Tissue and Is Associated with a Poor Prognosis in Esophageal Squamous Cell Carcinoma.
Journal: Oncology
Published: June 20, 2021
Myosin Light Chain 9/12 Regulates the Pathogenesis of Inflammatory Bowel Disease.
Journal: Frontiers in immunology
Published: August 14, 2020
Development of TP53-Targeted Treatment in Esophageal Squamous Cell Carcinoma Using Cancer Genomic Profiling Test
Journal: Gan to kagaku ryoho. Cancer & chemotherapy
Published: October 22, 2019
The Antitumor Effects of Metformin on Gastric Cancer In Vitro and on Peritoneal Metastasis.
Journal: Anticancer research
Published: September 14, 2018
A Case Describing Treatment with FOLFIRI plus Bevacizumab after a Self-Expandable Metallic Stent Placement for Local Recurrence
Journal: Gan to kagaku ryoho. Cancer & chemotherapy
Published: July 21, 2018
Antitumor effects of metformin are a result of inhibiting nuclear factor kappa B nuclear translocation in esophageal squamous cell carcinoma.
Journal: Cancer science
Published: September 15, 2017
The concentration of programmed cell death-ligand 1 in the peripheral blood is a useful biomarker for esophageal squamous cell carcinoma.
Journal: Esophagus : official journal of the Japan Esophageal Society
Published: August 29, 2017
ZNF750 Expression Is a Potential Prognostic Biomarker in Esophageal Squamous Cell Carcinoma.
Journal: Oncology
Published: August 04, 2017
A Case of Malignant Phyllodes Tumor Effectively Treated by Radiation Therapy as a Palliative Medicine
Journal: Gan to kagaku ryoho. Cancer & chemotherapy
Published: January 26, 2016
Last Updated: 09/26/2026